Back

The effect of influenza vaccination in patients with heart failure: a systematic review and meta-analysis

12 May 2026 (10:19 - 10:27)
Organised by: Logo
Congress Presentation Part of: From evidence to practice: optimising guideline-directed therapy and prevention Prevention Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Ana Karyn Ehrenfried Freitas

Cruz Vermelha Brasileira Hospital, Curitiba (Brazil)

6 More presentations in this session

Presentation thumbnail
Evaluating the impact of electronic alerts on guideline implementation of heart failure medical therapies in the Netherlands: the Dutch PROMPT-HF-study
Assistant Professor A. Uijl (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Real-world implementation of guideline-directed medical therapy in heart failure across the ejection fraction spectrum: Insights from iCaReMe Global Registry
Doctor A. Hadaoui (Algiers, DZ)
Abstract Slides
Presentation thumbnail
Mineralocorticoid receptor antagonists in heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of safety and clinical outcomes
Doctor R. Ali (Pembroke Pines, US)
Abstract
Presentation thumbnail
Nurse led titration of guideline-directed medical therapy for heart failure in Italy: an operative flow chart
Doctor M. Barisone (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
Revisiting Optimal Medical Therapy in HFrEF: Do Men and Women Need Different Doses? Evidence from KorAHF III registry
Doctor M. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
From evidence to practice: optimising guideline-directed therapy and prevention
Video

The Event

Event poster

Heart Failure 2026

12 May 2026 10:19 CET
You may be interested in
thumbnail
Congress Presentation
The impact of Flu vaccine in patients with heart failure
thumbnail
Congress Presentation
Population Assessment of Influenza and Disease Activities
thumbnail
Congress Session
Late-Breaking Clinical Trials: vaccinations in cardiovascular prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources